GlassScriptPrepare for your visit
Mark R Weinstock
Podiatrist · Maywood, NJ · NPI 1992709430
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,431.42
in general payments reported to CMS, 2019-2025 · $682 in 2025
The $682 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Who reported paying
General payments only, top 6 by amount.
- Smith+Nephew, INC. $458.18
- Amgen INC. $423.53
- Treace Medical Concepts, INC. $277.44
- Paratek Pharmaceuticals, INC. $240.58
- Organogenesis INC. $220.63
- Abbott Laboratories $216.59
Drugs and devices associated with these payments
Kerecis Omega3 Surgiclose Krystexxa Nuzyra Nimbl Flexitouch Plus Lapiplasty System Kerecis Omega3 Graftguide Kerecis Omega3 Marigen Xperience Blastx Surgx Stravix
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Mark Weinstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/419893/mark-r-weinstock